Your browser doesn't support javascript.
loading
Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge, Philippe-Yves; Murji, Ally; Vilos, George A; Allaire, Catherine; Leyland, Nicholas; Singh, Sukhbir Sony.
Affiliation
  • Laberge PY; Québec, QC. Electronic address: philippe.laberge@fmed.ulaval.ca.
  • Murji A; Toronto, ON.
  • Vilos GA; London, ON.
  • Allaire C; Vancouver, BC.
  • Leyland N; Hamilton, ON.
  • Singh SS; Ottawa, ON.
J Obstet Gynaecol Can ; 41(10): 1521-1524, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31548041

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Leuprolide / Antineoplastic Agents, Hormonal / Contraceptive Agents, Hormonal / Leiomyoma / Menorrhagia / Norpregnadienes Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: J Obstet Gynaecol Can Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2019 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Leuprolide / Antineoplastic Agents, Hormonal / Contraceptive Agents, Hormonal / Leiomyoma / Menorrhagia / Norpregnadienes Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Female / Humans Language: En Journal: J Obstet Gynaecol Can Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2019 Document type: Article Country of publication: Países Bajos